Bioregenerative Habitat Project
Radioprotective, self-sufficient human and agricultural habitat with archaeological-anthropogenic soils (for off-Earth survival)
A novel habitat concept, integrating human and organic matter radiation protection encountered in the space environment. The habitat aims to maximise human and crop health, creating a self-sufficient (enclosed) self-contained modular, expandable system which incorporates archaeological-anthropogenic soils and biological waste management. The system design is able to reuse or reincorporate all human and plant solid and liquid waste, as well as gaseous waste (carbon monoxide and carbon dioxide) and return clean water, soil nutrients and oxygen into the habitat.
The bioregenerative habitat could provide a suitable and sustainable environment for all off-Earth locations including the Moon, Mars, asteroids. It has been specifically designed to accommodate humans and agriculture, protecting all life forms from space radiation and space environmental insults, whilst encouraging maximal human health outcomes.
- Investment for final habitat design development, material testing, and modular construction.
- Return: % share of final product and sales commensurate to level of investment, to a maximum of 49% shareholding.
The space environment is an incredibly stressful environment for humans and other organic life forms adapted to Earth’s gravity. The human microbiome is integral to human growth and development, cognitive function, nutritional and immune status, and general health. The microbiome has two habitats: the skin and appendages and the oral-gastrointestinal tract. It can be argued that the uterus is a third habitat, as it is technically external to the human body.
Spaceport Australia Pty Ltd has created a supplement to contribute to human health and functioning in the space environment. Elements of the supplement have been demonstrated to be anti-tumor, anti-cancer, anti-viral, anti-inflammatory, bone mass protective and clinically supportive of the immune system. It is anticipated that V/Q oxygen exchange in low oxygen environments (i.e., off-Earth habitats, and spacecraft) will improve by 10%, helping offset cognitive changes experienced in enclosed space environments (space stations, off-Earth habitats, and spacecraft).
The supplement has strong potential for adjuvant medical use on Earth.
- Investment to complete clinical trials and regulatory application (envisioned multiple jurisdictions).
- Return: % share of final product and sales commensurate to the level of investment to a maximum of 49% shareholding.